LINK Healthcare PTE LTD and photonamic GmbH & Co. KG sign a licensing agreement for Alacare®, a new therapeutic for the treatment of actinic keratosis. This licensing agreement gives LINK exclusive rights to market Alacare® in Australia, New Zealand and South Africa. Alacare® is a photodynamic therapeutic in the form of a medicated patch for

Melbourne, Australia, June 20th 2013: Australian biotechnology company Avexa Limited [ASX:AVX] today announced that it has signed a binding term sheet with Link Healthcare Pte Ltd (LINK) for the development and commercialization of Avexa’s lead HIV drug apricitabine (ATC). “Avexa is delighted to expand our collaboration with Link” said Mr Iain Kirkwood, Chairman of Avexa,